Hemispherx Biopharma Inc (NYSE American:HEB)

0.3207
Delayed Data
As of Jun 22
 +0.0011 / +0.34%
Today’s Change
0.28
Today|||52-Week Range
0.74
-7.31%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.32
Today’s open0.33
Day’s range0.31 - 0.33
Volume286,482
Average volume (3 months)583,455
Market cap$11.6M
Data as of 8:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+14.71%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+375.00%
P/E ratioNM
Price/Sales22.70
Price/Book1.13

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...+0.01+7.89%
ITUSITUS Corp+0.13+4.26%
----
SBOTStellar Biotechnolog...-0.25-11.96%
Data as of 4:00pm ET, 06/22/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$437.0K
Annual profit (last year)-$8.3M
Net profit margin-1,889.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Vice Chairman, President &
CEO
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Orlando, Florida

Forecasts